Is Freeport-McMoRan (FCX) a risky stock?
As of July 21, 2026, Clavix grades Freeport-McMoRan (FCX) C- for risk, a composite score of 54 out of 100 on an A+ to F scale, which puts FCX in the "average" band. The grade is a risk read for educational purposes, not a buy or sell recommendation.
Grade as of July 21, 2026. Clavix regrades every trading day.
The five risk dimensions behind FCX's grade
Each Clavix grade is a composite of five independent reads. Higher is safer. Here is how FCX scores on each, as of July 21, 2026.
What's moving FCX's risk right now
Company-specific signals Clavix flags behind FCX's current grade, drawn from recent news and filings as of July 21, 2026.
Two asset managers opened or added to positions in FCX last quarter, including a $44.27 million investment by SEB. Meanwhile, Barings LLC trimmed its holding by about 39%. Net effect on shares is unclear.
Sell-side analysts expect Freeport-McMoRan to post earnings above consensus when it next reports. A beat could support the share price, while a miss would likely do the opposite.
What a C- grade means
On the Clavix A+ to F scale, FCX's composite of 54 falls in the C band (50–64), read as "average." The scale is fixed, so the meaning never moves.
This page is generated from Clavix's own risk model and is for educational purposes only. It is not investment advice or a recommendation to buy or sell FCX or any security. Grades are risk indicators, not predictions of return. Data may be delayed.